Vaccines Updated During November 2021, From Oldest to Newest

Ixiaro (Japanese Encephalitis Vaccine, Inactivated, Adsorbed)

JEV.

Vetter Pharma Fertigung GmbH & Co. KG2 November 2021

MenQuadfi (NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN, NEISSERIA…)

MenQuadfi is a vaccine indicated for active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A. C. W, and Y. MenQuadfi is…

Sanofi Pasteur Inc.2 November 2021

Trumenba (Meningococcal Group B Vaccine)

Trumenba is indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. Trumenba is approved for use in individuals 10 through 25 years of…

Wyeth Pharmaceutical Division of Wyeth Holdings LLC23 November 2021

PREHEVBRIO (Hepatitis B Vaccine (Recombinant))

PREHEVBRIO is indicated for prevention of infection caused by all known subtypes of hepatitis B virus. PREHEVBRIO is approved for use in adults 18 years of age and older. PREHEVBRIO is…

VBI Vaccines (Delaware) Inc.30 November 2021

Vx Labels

Vaccine Sections

Vaccine Information by RSS

About

As the leading independent provider of trustworthy vaccine information, our database comes directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. VxLabels.com provides the full vaccine subset of the FDA's repository. Vaccine information provided here is not intended as a substitute for direct consultation with a qualified health professional.